Global challenges, like the COVID-19 pandemic, underscore the value of international coordination and collaboration. In the case of pandemics, this need comes into play not only in managing and mitigating the spread of the disease, but also in the development of treatment therapies and vaccines. Indeed, the first COVID-19 vaccine approved by the U.S. Federal Drug Administration in December 2020 arose from an international collaboration between U.S. and German-based biotech companies, each led by immigrants from Greece and Turkey, respectively.